Clinical MedicineUpdated Aug 6, 2026Version v1
Reviewed milestones, validation shifts, standards, datasets, and debates linked to public evidence.
Evidence from American Journal of Psychiatry indicates that OBJECTIVE: Disruptions in connectivity between the frontal and temporal lobes may explain some of the symptoms observed in schizophrenia. This is tracked as a clinical because it changes how Whole-brain connectomics is understood, validated, or applied.
Evidence from Human Brain Mapping indicates that Recent studies have demonstrated small-world properties in both functional and structural brain networks that are constructed based on different parcellation approaches. This is tracked as a validation because it changes how Whole-brain connectomics is understood, validated, or applied.
Evidence from BMC Neuroscience indicates that BACKGROUND: Although a large body of knowledge about both brain structure and function has been gathered over the last decades, we still have a poor understanding of their exact relationship. This is tracked as a clinical because it changes how Whole-brain connectomics is understood, validated, or applied.
Evidence from Developmental Cognitive Neuroscience indicates that Human brain function undergoes complex transformations across the lifespan. This is tracked as a milestone because it changes how Whole-brain connectomics is understood, validated, or applied. It is supported by 2 papers in the same timeline signal.